Story thread · 2 reports / 2 sources
Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
seekingalpha.com · 6d
How the coverage leans
Across 2 sources · syndicated copies counted once
First report: Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map — genengnews.com, 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.